| Ticker: | PSTV |
| Current Price: | $3.87 |
| % Daily Change: | -3.25% |
| Volume (1,000s): | 96.53 |
| Average Volume (1,000s): | 168.60 |
| Market Cap (M): | $9.36 |
Plus Therapeutics, Inc.
4200 Marathon Boulevard
Suite 200
Austin, TX 78756
United States
Plus Therapeutics (Nasdaq: PSTV) is a U.S. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. Our lead drug candidate, Rhenium-186 Nanoliposome, is being evaluated in the NIH-supported multi-center ReSPECT clinical trials for patients with recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancer.